Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does COBIMETINIB Cause Multiple organ dysfunction syndrome? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Multiple organ dysfunction syndrome have been filed in association with COBIMETINIB (Cotellic). This represents 0.3% of all adverse event reports for COBIMETINIB.

14
Reports of Multiple organ dysfunction syndrome with COBIMETINIB
0.3%
of all COBIMETINIB reports
12
Deaths
12
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From COBIMETINIB?

Of the 14 reports, 12 (85.7%) resulted in death, 12 (85.7%) required hospitalization, and 5 (35.7%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for COBIMETINIB. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does COBIMETINIB Cause?

Diarrhoea (412) Off label use (411) Rash (369) Pyrexia (332) Death (231) Nausea (206) Fatigue (198) No adverse event (178) Vomiting (168) Acute kidney injury (133)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which COBIMETINIB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

COBIMETINIB vs COCAETHYLENE COBIMETINIB vs COCAINE COBIMETINIB vs COCOA BUTTER\PHENYLEPHRINE COBIMETINIB vs COD LIVER OIL COBIMETINIB vs CODEINE

Related Pages

COBIMETINIB Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome COBIMETINIB Demographics